FDA grants clearance to Physio's updated chest compression system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has granted 510(k) market clearance to Physio-Control, a wholly owned subsidiary of Medtronic, for its Lucas 2, the next-generation Lucas chest compression system.

Developed and manufactured by the Lund, Sweden-based Jolife and distributed exclusively in the U.S. by Physio-Control, the Lucas 2 is an automated, battery-powered device that is designed to give uninterrupted compressions to victims in cardiac arrest, the company said.

The Redmond, Wash.-based Physio-Control said that its Lucas 2 can be powered either by battery alone or using a wall or car electricity outlet. The battery uses Lithium Ion Polymer technology and can operate for up to 45 minutes on a single battery. The device is equipped with Smart Restart functionality. The Lucas 2 weighs 17.2 lbs (7.8kg) and fits into a backpack measuring just 25.6h x 13w x 19.8d inches (65h x 33w x 25d centimeters).